
AOD 9604 (5mg)
AOD-9604 is a modified fragment of human growth hormone (amino acids 176–191) studied in research models for lipolytic activity without the somatogenic effects of full-length GH.
Mechanism of Action
AOD-9604 mimics the lipolytic domain of GH, activating beta-3 adrenergic receptors and downstream fat metabolism pathways in adipocyte research models without significant IGF-1 elevation.
Research Applications
- Adipocyte lipolysis assays
- Beta-3 adrenergic receptor studies
- Comparative GH fragment research
Specifications
| sequence | H-Tyr-Leu-Arg-Ile-Val-Gln-Cys-Arg-Ser-Val-Glu-Gly-Ser-Cys-Gly-Phe-OH (modified fragment) |
| molecular Weight | 1815.1 Da |
| cas | 221231-10-3 |
| appearance | White lyophilized powder |
Reconstitution (Laboratory)
Reconstitute with bacteriostatic water. Standard sterile technique.
Storage & Handling
Lyophilized: 2–8 °C. Reconstituted: refrigerate.
Quality Assurance
Every lot undergoes independent third-party HPLC purity analysis, mass spectrometry identity confirmation, and endotoxin testing (<0.5 EU/mg). Certificate of Analysis (COA) is stored against the SKU lot number and available through your research account portal.